TGTX
TGTX
NASDAQ · Biotechnology

Tg Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$53.94
-0.46 (-0.85%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 12 80%
Hold 2 13%
Sell 1 7%
Price Target
Analyst Price Target +15.7% upside
Low Target $43.17
Average Target $62.39
High Target $72.87
Current Price $53.94
Current
$53.94
Target
$62.39
$43.17 $62.39 avg $72.87
Scenario Analysis
Bear Case
$43.17
-20.0%
Low target
Base Case
$62.39
+15.7%
Avg target
Bull Case
$72.87
+35.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$54.07
-0.2% from high
52-Week Low
$25.28
+113.4% from low
50-Day SMA
$30.02
+79.7% vs SMA
200-Day SMA
$32.89
+64.0% vs SMA
RSI (14)
46.3
Neutral
Target vs 52W High
$62.39
+15.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%